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Background: N-myc downstream regulated gene 2 (NDRG2) 
is a member of the NDRG gene family. Our previous report 
indicated a possible role for NDRG2 in regulating the cyto-
kine, interleukin-10 (IL-10), which is an important im-
munosuppressive cytokine. Several pathways, including 
p38-MAPK, NF-κB, and JAK/STAT, are used for IL-10 pro-
duction, and the JAK/STAT pathway can be inhibited in a 
negative feedback loop by the inducible protein, SOCS3. In 
the present study, we investigated the effect of NDRG2 
gene expression on IL-10 signaling pathway that is modu-
lated via SOCS3 and STAT3. Methods: We generated 
NDRG2-overexpressing U937 cell line (U937-NDRG2) and 
treated the cells with PMA to investigate the role of NDRG2 
in IL-10 production. U937 cells were also transfected with 
SOCS3- or NDRG2-specific siRNAs to examine whether the 
knockdown of SOCS3 or NDRG2 influenced IL-10 
expression. Lastly, STAT3 and SOCS3 induction was meas-
ured to identify the signaling pathway that was associated 
with IL-10 production. Results: RT-PCR and ELISA assays 
showed that IL-10 was increased in U937-mock cells upon 
stimulation with PMA, but IL-10 was inhibited by over-
expression NDRG2. After PMA treatment, STAT3 phosphor-
ylation was decreased in a time-dependent manner in U937- 
mock cells, whereas it was maintained in U937-NDRG2 cells. 
SOCS3 was markedly reduced in U937-NDRG2 cells com-
pared with U937-mock cells. IL-10 production after PMA 
stimulation was reduced in U937 cells when SOCS3 was in-
hibited, but this effect was less severe when NDRG2 was 
inhibited. Conclusion: NDRG2 expression modulates SOCS3 
and STAT3 activity, eventually leading to the inhibition of 
IL-10 production.
[Immune Network 2010;10(6):219-229]
INTRODUCTION
N-myc downstream regulated gene 2 (NDRG2), a member of 
a new family of genes involved in cell differentiation, is nor-
mally expressed in the brain, heart, and muscle (1). It has 
also  been  reported  that  NDRG2  is  expressed  specifically  in 
dendritic cells (DCs) differentiated from monocytes or CD34
＋ 
progenitor cells (2). NDRG2 expression in breast cancer cells 
has been shown to inhibit activation of signal transducer and 
a c t i v a t o r  o f  t r a n s c r i p t i o n  3  ( S T A T 3 )  v i a  i n d u c t i o n  o f  s u p -
pressor of cytokine signaling 1 (SOCS1) (3). NDRG2 has sev-
eral roles in cell growth, differentiation and apoptosis, but its 
function  remains  to  be  clarified  (2,4).
    In a previous report, we found a possible role for NDRG2 
in regulating the cytokine, interleukin-10 (IL-10). IL-10 is an 
important  anti-inflammatory  cytokine  with  a  crucial  role  in 
preventing  inflammatory  and  autoimmune  pathologies  (5). 
IL-10 functions as an immune suppressor and can also pro-
mote the growth of lymphocytes in vivo (6). As IL-10 limits 
the immune response to pathogens, this cytokine thus pre-
vents  damage  to  the  host.  IL-10  is  produced  by  T  cells,  B 
cells, dendritic cells, and monocytes/macrophages, and its im-
munosuppressive  activity  has  been  documented  in  IL-10 
knockout  mice,  which  have  increased  autoimmune  disease 
and increased resistance to infection (7-9). Because of its pro-NDRG2 Inhibits IL-10 Production in U937 Cells
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duction by many immune cells, IL-10 clearly plays a crucial 
role  as  a  feedback  regulator  of  diverse  immune  responses. 
IL-10 mediates its effect by binding to the heterodimeric IL-10 
r e c e p t o r  ( I L - 1 0 R ) ;  J a k 1  a n d  T y k 2  a r e  t h e n  t r a n s p h o s p h o r y -
lated  and  activated,  and  these  molecules  subsequently  acti-
vate the downstream transcription factor, STAT3, and in some 
cases, STAT1 and STAT5 (10-12). There are several mecha-
nisms of regulation  of IL-10 expression, and this regulation 
i s  d i f f e r e n t  d e p e n d i n g  o n  t h e  t y p e  o f  c e l l  o r  l o c a t i o n .  
Currently, studies investigating immunosuppressive processes 
of diverse cells or formation and maintenance of regulatory 
T  c e l l s  b y  I L - 1 0  a r e  b e i n g  p e r f o r m e d  ( 1 3 ) .
    p38 mitogen-activated protein kinase (p38-MAPK), nuclear 
factor-κB (NF-κB) and JAK/STAT pathways are the known 
signaling  pathways  for  innate  IL-10  production  (14,15).  In 
particular, activation of STAT3 is essential for the effects of 
IL-10 (16). Macrophages increase their production of IL-10 by 
activating  STAT3  in  an  autocrine  fashion,  and  the  activated 
STAT3 then plays an important role in inhibiting the activa-
tion of macrophages and neutrophils (7). In mouse T cells, 
the induction of IL-10 by IL-27 depends on both STAT1 and 
STAT3, and STAT3 is also involved in IL-6-mediated IL-10 ex-
pression (17-19). By contrast, a recent study in human mono-
cytes  describes  an  inhibitory  role  for  IL-27  on  IL-10  pro-
duction  through  STAT1  (20).  Another  study  suggests  that 
IL-10 induces its own expression by human monocyte-derived 
macrophages in an autocrine manner through the activation 
of  STAT3  (7).
    Activated STATs dimerize and migrate to the nucleus where 
they activate the transcription of specific genes among; some 
of these genes are members of the suppressors of cytokine 
signaling (SOCS) family (21). SOCS proteins (SOCS1-7 and cy-
tokine-inducible SH2-containing protein (CIS)) negatively reg-
ulate cytokine signaling pathways (22). The inducible SOCS3 
protein inhibits the JAK/STAT pathway in a negative feedback 
loop  using  a  variety  of  mechanisms  (23).  In  addition,  it  is 
known  that  SOCS3  plays  an  important  role  in  the  negative 
regulation  of  inflammatory  responses  via  the  induction  of 
IL-10.  Among  SOCS  family  members,  SOCS1,  SOCS3  and 
SOCS5 are mainly involved in the regulation of IL-4 and IL-10 
pathways. Both SOCS1 and SOCS3 inhibit JAK tyrosine kinase 
activity via their N-terminal kinase inhibitory region. SOCS1 
directly binds to the activation loop of JAK molecules through 
its Src-homology 2 domain, whereas SOCS3 inhibits the action 
of JAK molecules only in the presence of a receptor that it 
binds (24). However, both SOCS1 and SOCS3 are activated 
by  IL-4  or  IL-10  and  function  as  potent  inhibitors  of 
IL-4/STAT6  or  IL-10/STAT3  activation  (25).  It  has  been  re-
ported that targeted deletion of SOCS3 in macrophages results 
in  markedly  enhanced  IL-6-induced  STAT3  activation  (26).
    Monocytes are known to be one of the major sources of 
IL-10. In this study, we used the human monocytic cell line, 
U937, which was derived from malignant cells obtained from 
the  pleural  effusion  of  a  patient  with  histiocytic  lymphoma 
in 1974. U937 cells display many characteristics of monocytes 
a n d  h a v e  t h u s  s e r v e d  a s  a  m o d e l  f o r  t h e  d i f f e r e n t i a t i o n  o f  
monocytes and macrophages in vitro. This cell line matures 
and differentiates in response to a number of soluble stimuli 
and adopts the morphology and characteristic features of ma-
ture  macrophages.  Herein,  we  generated  NDRG2-overex-
pressing U937 cells and treated them with a stimulus to inves-
tigate the role of NDRG2 in IL-10 production. We also inves-
tigated whether the IL-10 signaling pathway was modulated 
via  SOCS3  and  STAT3.
MATERIALS AND METHODS
Cell culture and treatment
U937 cells were grown in RPMI (Gibco/Invitrogen, Carlsbad, 
CA) supplemented with 10% heat-inactivated fetal bovine se-
rum (Gibco). Cells were maintained in an atmosphere of 5% 
CO2 i n  a  3 7
oC  humidified  incubator.  Phorbol  12-myristate 
13-acetate  (PMA)  was  purchased  from  Sigma-Aldrich  (St. 
Louis, MO) and cucurbitacin I, a selective inhibitor of JAK/ 
STAT3, and AG490, an inhibitor of constitutive STAT3-DNA 
binding,  were  purchased  from  Calbiochem  (Merck  KGaA, 
Darmstadt,  Germany).
Transfection
The  NDRG2  gene  was  cloned  into  the  pcDNA3.1  vector 
(Invitrogen,  Carsbad,  CA)  and  the  resulting  pcDNA3.1- 
NDRG2 plasmid was introduced into U937 cells by electro-
poration with a Gene Pulser (Bio-Rad, Hercules, CA) at 960μF 
and 300 V. Transfectants resistant to 1 mg/ml G418 (Sigma) 
were  screened  for  NDRG2  expression.  NDRG2  expression 
was confirmed by RT-PCR and western blotting. NDRG2-ex-
pressing  cells  were  expanded  in  culture  for  further  study.
RNA interference
The SMARTpool siRNA specific for human SOCS3 was pur-
chased from Dharmacon (Lafayette, CO), and NDRG2-specific 
siRNA and control non-targeting siRNA were purchased from NDRG2 Inhibits IL-10 Production in U937 Cells
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Santa Cruz Biotechnology (Santa Cruz, CA). U937-mock and 
NDRG2-overexpressing cells were transfected with 100 nM of 
control, SOCS3-  or NDRG2-specific siRNAs  using an Amaxa 
Nucleofector
TM (program V-001, Amaxa, Cologne, Germany). 
After  transfection,  cells  were  immediately  placed  in  a  37
oC 
humidified  incubator.
Reverse transcription (RT)
Total RNA from harvested cells was isolated using TRI reagent 
(Molecular Research Center, Cincinnati, OH) and 5μg of total 
RNA was reverse transcribed (RT) into cDNA. For the RT re-
action, RNA was first incubated with an oligo-(dT) primer at 
70
oC to denature the RNA secondary structure and then in-
cubated at room temperature for 10 min to allow the primer 
to  anneal  to  the  RNA.  Other  components  of  the  RT  assay, 
including dNTPs (Bioneer, Daejeon, Korea), M-MLB reverse 
transcriptase, and RT  buffer (Promega,  Madison, WI), were 
then added to the reaction. The RT reaction was performed 
at 37
oC for 1 h and then at 100
oC for 5 min. The RT product 
was  then  used  as  a  template  for  a  20μl  PCR  reaction.
Polymerase chain reaction (PCR)
Oligonucleotide primers for PCR were designed according to 
the published sequences (GenBank). PCR primers were pur-
chased from Bioneer, or GENOTECH (Daejeon, Korea). The 
following  primer  sequences  were used:  β-actin: 5’-cca  cac 
ctt cta caa tga gc-3’ (sense), 5’-tga ggt agt cag tca ggt cc-3’ 
(antisense); NDRG2: 5’-gga ttc atg gcg gag ctg cag gag g-3’ 
(sense), 5’-gaa ttc tca aca gga gac ctc cat ggt-3’ (antisense); 
IL-10: 5’-gat gcc ttc agc aga gtg aag a-3’ (sense), 5’-cat ggc 
ttt  gta gat  gcc  ttt c-3’ (antisense); SOCS1: 5’-aga ccc  ctt ctc 
acc  tct  tg-3’ ( s e n s e ) ,  5 ’- c t g  c a c  a g c  a g a  a a a  t a a  a g c - 3 ’ 
(antisense);  SOCS2:  5’-gga  tgg  tac  tgg  gga  agt  atg  act-3’ 
(sense),  5’-agt  gga  tca  gat  gaa  cca  cac  tct-3’ ( a n t i s e n s e ) ;  
SOCS3:  5’- c a c  a t g  g c a  c a a  g c a  c a a  g a - 3 ’ ( s e n s e ) ,  5 ’-aag  tgt 
ccc  ctg  ttt  gga  gg-3’  (antisense);  SOCS4:  5’-aga  gaa  ggt  cct 
atg  act  gg-3’ ( s e n s e ) ,  5 ’-ggg  cat  cga  tgc  cat  cat  aa-3’ 
(antisense);  SOCS5:  5’- c a g  t t c  t g c  a a t  t c c  a c a  a g - 3  ( s e n s e ) ,  
5’-gac tgg ttc tcg ttc caa cc-3 (antisense). PCR products were 
electrophoresed on a 1% agarose gel and visualized by ethi-
dium  bromide  staining.
Western blot analysis
U937 cells were treated with the indicated concentration (50 
ng/ml) of PMA for 0∼24 h. The treated cells and untreated 
control  cells  were  washed  with  PBS  (WelGENE,  Daegu, 
Korea) and immediately resuspended in ice-cold lysis buffer 
(M-PER
Ⓡ M a m m a l i a n  p r o t e i n  e x t r a c t i o n  r e a g e n t ,  P i e r c e ,  
Rockford, IL) for 20 min. Supernatant fractions were recov-
ered by centrifugation at 12,000 rpm for 15 min. For immuno-
blotting,  cell  lysates  containing  equivalent  amounts  of  total 
protein were mixed with 5X sample buffer and resolved on 
a  SDS-polyacrylamide  gel.  Separated  proteins  were  trans-
ferred to a Hybond-P (Amersham Biosciences, Burkes, UK) 
membrane. Membranes were incubated in 5% skim milk (BD 
B i o s c i e n c e s ,  S a n  J o s e ,  C A )  in  TBS-T  (20  mM  Tris-HCL,  pH 
7.5, 137 mM NaCl, 0.05% tween-20) for 1 h at room temper-
ature, washed with TBS-T and incubated with primary anti-
body  overnight  at  4
oC.  The  membranes  were  washed  with 
TBS-T and incubated with secondary antibody for 2 h at room 
temperature.  Protein  bands  were  visualized  by  enhanced 
chemiluminescence  (SuperSignal  West  Pico  Chemilumines-
cent Substrate, Pierce, Rockford, IL) using a LAS 3000 imaging 
system  (FUJIFILM  Corporation,  Tokyo,  Japan).
Antibodies for western blotting
A n ti bo d ie s ag a in st  t he  fo ll ow in g  p ro te in s w e re  u se d i n th is 
study:  STAT3  and  phospho-STAT3  (Tyr705)  (Cell  Signaling, 
Danvers, MA); SOCS1, SOCS2, SOCS3, and actin (Santa Cruz, 
CA); NDRG2 (produced by our laboratory). Peroxidase-con-
jugated  AffiniPure  goat  anti-rabbit  IgG  (Jackson  Immuno-
Research Laboratories, West Grove, PA), bovine anti-goat IgG 
HRP(Santa  Cruz),  and  goat  anti-mouse  IgG  (Sigma-Aldrich) 
were  also  used.
Cell proliferation using MTT assay and hemocyto-
meter
Cells  (2×10
4  cells/well)  were  cultured  in  96-well  culture 
plates  for  24  h  and  treated  with  MTT  (3-(4,5-dimethylth-
iazol-2-yl)-2,5-diphenyltetrazolium  bromide)  for  2  h.  Cells 
were harvested and centrifuged at 1,200 rpm for 5 min. The 
pellets  were  dissolved  in  200μl  DMSO.  Absorbance  was 
measured  at  540  nm  using  an  ELISA  reader  (Victor  3
TM, 
PerkinElmer,  Waltham,  MA).  For  cell  counting  by  micro-
scope, cells (1×10
4 cells/well) in 6-well culture plates were 
cultured for 1 to 4 days and centrifuged at 1,200 rpm for 5 
min. Viable cells, which are visible by light microscopy, were 
enumerated  using  a  hemocytometer.
Cytokine detection by ELISA
IL-10 production was assessed after 24 h in culture by collect-
ing  the  supernatants  from  U937  cells  (3×10
5  cells/ml)  that NDRG2 Inhibits IL-10 Production in U937 Cells
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Figure 1. PMA stimulation of U937 cells induces IL-10 production.
(A) Dose- and time-dependent increase in IL-10 mRNA after PMA 
stimulation. U937 cells were stimulated with PMA for different time
periods and harvested for mRNA analysis. Transcript levels of IL-10 
and β-actin (loading control) were determined by RT-PCR. (B) U937
cells were stimulated with different concentrations of PMA for 24 h. 
Cells were harvested, and IL-10 protein levels in the supernatants 
were determined by ELISA. Data represent the mean±SD of dupli-
cates.
had undergone PMA treatment. IL-10 levels were measured 
using the human IL-10 ELISA kit (Peprotech, Rocky Hill, NJ) 
according to the manufacturer’s instructions. Each sample was 
tested in duplicate and quantified using the Multi Detection 
Microplate  SpectraMax  M5  (Molecular  Devices,  Sunnyvale, 
CA)  at  405  nm  and  650  nm  absorbance.
Statistical analysis
Statistical  analysis  for  the  comparison  between  groups  was 
performed  using  student’s  t-test  and  represented  by  the 
mean±SD.
RESULTS
NDRG2 inhibits IL-10 production in U937 cells
To examine IL-10 production in U937 cells, cells were stimu-
lated with 50 ng/ml of PMA, and IL-10 mRNA was measured 
by RT-PCR. IL-10 expression increased in a time-dependent 
manner upon PMA stimulation in U937 cells (Fig. 1A). After 
12 h of stimulation with PMA, IL-10 transcripts increased in 
a dose-dependent manner. Similarly, PMA treatment induced 
IL-10  protein  production  in  U937  cells  when  measured  by 
ELISA  (Fig.  1B).  We  hypothesized  that  NDRG2  gene  ex-
pression might inhibit IL-10 production. To determine the re-
lationship between NDRG2 and IL-10 expression, U937-mock 
cells  and  U937  cells  overexpressing  NDRG2  (U937-NDRG2) 
w e r e  t r e a t e d  w i t h  P M A ,  a n d  I L - 1 0  m R N A  l e v e l s  w e r e  d e -
termined by RT-PCR. As shown in Fig. 2A, IL-10 mRNA in 
U937-NDRG2 cells was suppressed compared to wild type or 
mock-transfected cells. The measurement of IL-10 by ELISA 
showed  that  whereas  IL-10  production  was  remarkably  in-
creased  in  U937-mock  cells  upon  PMA  stimulation,  it  was 
strongly  reduced  in  U937-NDRG2  cells  (Fig.  2B).  Although 
overexpression  of  the  gene  itself  did  not  affect  cell  pro-
liferation (Fig. 2C), IL-10 production was corrected based on 
cell numbers because U937-NDRG2 cells showed growth rate 
faster  than  wild-type  cells  upon  PMA  stimulation  (data  not 
shown). These data indicate the negative effect of NDRG2 ex-
pression  on  both  IL-10  protein  production  and  IL-10  ex-
pression  levels.
Expression of IL-10 and SOCS genes upon PMA 
stimulation
Based  on  our  previous  report  (3),  we  hypothesized  that 
NDRG2  might  inhibit  IL-10  production  through  SOCS  and 
STAT signaling. SOCS genes (SOCS1-5) have emerged as key 
physiological  regulators  of  cytokine  responses,  including 
those that regulate the immune system (27). To test this hy-
pothesis,  U937-mock  and  U937-NDRG2  cells  were  treated 
with PMA (50 ng/ml) for 0, 15, 30, and 60 min and SOCS 
gene  expression  was  detected  by  RT-PCR.  Interestingly, 
SOCS3  expression  was  significantly  upregulated  upon  PMA 
stimulation in U937 cells but was only slightly increased in 
U937-NDRG2 cells. In contrast, there was no significant differ-
ence in the levels of other SOCS family members (SOCS1, 2, 
4, 5) between U937-mock and U937-NDRG2 cells (Fig. 3A). 
These expression patterns were maintained at 24 h after PMA 
treatment  (Fig.  3B).  Although  PMA  treatment  appeared  to NDRG2 Inhibits IL-10 Production in U937 Cells
Eun Byul Lee, et al.
223 IMMUNE NETWORK http://www.ksimm.or.kr Volume 10 Number 6 December 2010
Figure 2. IL-10 production is reduced by NDRG2 expression. (A) U937, U937-mock and U937-NDRG2 cells were stimulated with PMA (50 
ng/ml) for different time periods and harvested for mRNA analysis. Transcript levels of IL-10 and β-actin were determined by RT-PCR. (B) 
U937-mock and U937-NDRG2 cells (3×10
5 cells/ml) were stimulated with PMA (50 ng/ml) for 24 h. The levels of IL-10 in culture supernatants 
were determined by ELISA and corrected based on cell numbers after cell counting. Data represent the mean±SD of duplicates. (C) Cells (2×10
4
cells/well) were cultured in 96-well culture plates for 24 h and treated with MTT for 2 h. The cells were harvested and centrifuged at 1,200
rpm for 5 min. The pellets were dissolved in 200μl of DMSO, and absorbance was measured at 540 nm using an ELISA reader (upper). For 
cell counting by microscope, cells (5×10
5 cells/well) in 6-well culture plates were cultured for 1 to 4 days and centrifuged at 1,200 rpm for 
5 min. Viable cells, which are visible by light microscopy, were enumerated using a hemocytometer. Data represent the mean±SD of triplicates.
s l i g h t l y  i n c r e a s e  N D R G 2  t r a n s c r i p t  l e v e l s  a s  a  r e s u l t  o f  t h e  
vector used for the transfection, its effect on protein level was 
negligible (see below). These results indicate that NDRG2 ex-
pression inhibits IL-10 induction in U937 cells when cells are 
simulated  with  PMA,  and  the  expression  pattern  of  SOCS3 
mirrors  that  of  IL-10.
Effect of NDRG2 expression on SOCS3 and STAT3 
expression after PMA stimulation
IL-10 production has effects on many immune cells, affirming 
its crucial role as a feedback regulator of diverse immune re-
sponses (15). As mentioned above, p38-MAPK, NF-κB and 
JAK/STAT pathways are known signaling pathways for innate 
IL-10 production. In particular, STAT3 has an important role 
in  IL-10  production  and  is  associated  with  several  cellular 
signals. In addition, it has been reported that targeted dele-
tion of SOCS3 in macrophages results in markedly enhanced 
STAT3  activation  (28).  When  we  measured  activation  of 
STAT3,  we  found  that  phosphorylated  STAT3  levels  sig-
nificantly decreased in U937-mock cells after PMA stimulation, 
whereas these levels were largely unchanged in U937-NDRG2 
cells  (Fig.  4A).  Because  we  observed  decreased  levels  of 
SOCS3 mRNA when NDRG2 was overexpressed, SOCS3 ex-
pression  and  STAT3  phosphorylation  were  examined  toge-
ther. After PMA stimulation, protein levels of SOCS1, 2, and 
3 and phoshporylated STAT3 were assessed by western blot NDRG2 Inhibits IL-10 Production in U937 Cells
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Figure 3. IL-10 and SOCS3 mRNA levels after PMA stimulation are 
reduced by NDRG2 expression. (A) U937-mock and U937-NDRG2
cells were stimulated at various times with 50 ng/ml of PMA. Cells
were harvested for analysis. Transcript levels of IL-10 and SOCS family 
members were determined by RT-PCR. (B) Cells were stimulated with
PMA for 24 h and harvested for mRNA analysis. Transcript levels of 
IL-10 and SOCS genes were determined by RT-PCR.
Figure 4. NDRG2 expression inhibits induction of SOCS3 but pro-
motes STAT3 phosphorylation after PMA stimulation. (A) U937-mock
and U937-NDRG2 cells were stimulated with 50 ng/ml of PMA for
15 or 30 min. Cell lysates were harvested and equal amounts of 
lysates were subjected to electrophoresis on SDS-PAGE. Western 
blotting was performed using STAT3-, pSTAT3- and NDRG2-specific
antibodies. (B) Cells were stimulated at various times with 50 ng/ml 
of PMA. Equal amounts of whole-cell lysates were subjected to 
electrophoresis on SDS-PAGE, and then western blotting was perform-
ed using specific antibodies.
at various time points. The data showed that phosphorylated 
STAT3 decreased in a time-dependent manner in U937-mock 
c e l l s ,  b u t  n o t  i n  U 9 3 7 - N D R G 2  c e l l s  ( F i g .  4 B ) .  I n  c o n t r a s t ,  
SOCS3 levels were decreased in cells overexpressing NDRG2 
but maintained at high levels in U937-mock cells. As SOCS1 
and SOCS2 proteins remained at basal levels during the ex-
p e r i m e n t a l  t i m e s ,  i t  a p p e a r e d  t h a t  t h e  i n h i b i t o r y  e f f e c t  o f  
NDRG2 is SOCS3-specific. Therefore, NDRG2 inhibits SOCS3 
expression and maintains STAT3 phosphorylation under con-
ditions  of  PMA  stimulation.
Increased IL-10 production upon STAT3 inhibition
T o  d e t e r m i n e  w h e t h e r  S T A T 3  i n h i b i t i o n  a f f e c t e d  I L - 1 0  p r o -
duction  induced  by  PMA,  cells  were  pretreated  with  the 
STAT3 inhibitor, cucurbitacin I, for 2 h and further incubated 
with PMA for 48 h. As shown in Fig. 5A, IL-10 expression 
in U937-mock cells was enhanced upon PMA treatment, but 
it was markedly increased by pretreatment with cucurbitacin 
I, indicating a role for STAT3 in inhibiting IL-10 production. 
In line with these data, IL-10 expression in U937-NDRG2 cells 
after  PMA  stimulation  was  also  significantly  upregulated  by 
pretreatment with cucurbitacin I or AG490 (Fig. 5B). Although 
the level of IL-10 transcripts was relatively low, increased lev-NDRG2 Inhibits IL-10 Production in U937 Cells
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Figure 5. Inhibition of STAT3 phosphorylation increases IL-10 
production. (A) U937-mock cells were pretreated with cucurbitacin I 
for 2 h followed by PMA treatment for 48 h. Cells were harvested 
for mRNA analysis. Transcript levels of IL-10 were determined by 
RT-PCR. (B) U937-NDRG2 cells were pretreated with cucurbitacin I 
or AG490 for 2 h followed by PMA treatment for 48 h. Cells were
harvested for mRNA analysis. Transcript levels of IL-10 were assessed
by RT-PCR. (C) U937-NDRG2 cells were treated in the same manner
as in (B). The levels of IL-10 in culture supernatants were determined
by ELISA. Data represent the mean±SD of duplicates.
Figure 6. Proliferation of siRNA-transfected U937 cells. U937-mock 
and U937-NDRG2 cells were transfected with siRNA control, SOCS3-
or NDRG2-specific siRNAs (100 nM) for 48 h. After transfection, cells
(1×10
4) were plated in 60 mm dishes and counted daily for 4 days.
els of IL-10 protein in U937-NDRG2 cells was also observed 
after  pretreatment  with  STAT3  inhibitors  followed  by  PMA 
stimulation (Fig. 5C). Together, these data suggest that high 
levels of phosphorylated STAT3 in NDRG2-transfected U937 
cells  may  play  a  role  in  the  inhibition  of  IL-10  upon  stim-
ulation  with  PMA.
Effect of SOCS3- or NDRG2-specific siRNAs on U937 
proliferation
Next, to test whether inhibition of SOCS3 affected IL-10 pro-
duction, U937-mock and U937-NDRG2 cells were transfected 
with specific small interfering RNAs (siRNAs; siRNA control, 
siSOCS3, siNDRG2). We first examined the proliferation ca-
pacity of siRNA-transfected cells by plating the cells in 60 mm 
dishes and counting the cells daily for 4 days using a hemo-
cytometer. The data showed that there were no differences 
in  cell  proliferation  between  the  five  cell  types  (Fig.  6).
IL-10 is down-regulated upon SOCS3 inhibition and 
recovered upon NDRG2 inhibition
To determine the effects of SOCS3 inhibition on IL-10 mRNA 
levels, siRNA-transfected U937-mock and U937-NDRG2 cells 
were stimulated with PMA, and gene expression was assessed 
b y  R T - P C R .  F i r s t ,  w e  m e a s u r e d  t h e  l e v e l  o f  S O C S 3  a n d  
NDRG2 expression in siRNA-transfected cells to confirm the 
knockdown of the genes. As shown in Fig. 7A, SOCS3 ex-
pression  was  attenuated  upon  transfection  with  siSOCS3  in 
both  U937-mock  and  U937-NDRG2  cells,  and  NDRG2  ex-
pression was attenuated upon transfection with siNDRG2 in 
U937-NDRG2 cells. Interestingly, reduced levels of SOCS3 eli-
cited the down-regulation of IL-10 mRNA in U937-mock cells, 
and IL-10 mRNA levels were recovered in U937-NDRG2 cells 
upon  knockdown  of  NDRG2.  These  results  suggest  that 
SOCS3  could  be  involved  in  IL-10  induction  in  U937  cells. 
Because the induction of IL-10 mRNA appeared to be asso-
ciated  with  SOCS3  expression  in  U937-mock  and  U937- 
NDRG2  cells,  we  investigated  whether  IL-10  protein  levels 
were also being decreased by SOCS3 inhibition. U937-mock 
and U937-NDRG2 cells were cultured for 24 h with PMA, and 
IL-10 production was measured by ELISA. As shown in Fig. 
7B, IL-10 levels in U937-mock cells transfected with siSOCS3 
were  significantly  reduced,  whereas  IL-10  levels  in  U937- 
NDRG2 cells remained unchanged in both control siRNA- and 
siSOCS3-transfected  cells.  The  latter  result  indicates  that 
SOCS3  expression  was  already  down-regulated  by  NDRG2- 
overexpression in U937-NDRG2 cells. As with the mRNA ex-NDRG2 Inhibits IL-10 Production in U937 Cells
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Figure 7. Effect of SOCS3 siRNA and NDRG2 siRNA on IL-10 mRNA
or protein expression. (A) U937-mock and U937-NDRG2 cells were 
transfected with siRNA control, SOCS3- or NDRG2-specific siRNAs 
(100 nM) for 48 h. Cells were then stimulated with PMA and 
harvested for mRNA analysis. Transcript levels of IL-10, SOCS3, and 
NDRG2 genes were determined by RT-PCR. (B) After siRNA 
transfection for 48 h, U937-mock and U937-NDRG2 cells (3×10
5
cells/ml) were stimulated with PMA for 24 h. The levels of IL-10 in 
culture supernatants were determined by ELISA. Data represent the 
mean±SD of duplicates.
pression  data  in  Fig.  7A,  IL-10  protein  production  was  re-
stored by knockdown of NDRG2. Thus, NDRG2 expression 
exerts a negative effect on IL-10 production through the mod-
ulation  of  SOCS3  and  STAT3.
DISCUSSION
NDRG2, a member of the N-myc downstream-regulated gene 
family  that  includs  NDRG1-4,  is  highly  expressed  in  many 
normal cells and tissues but it is expressed at low levels or 
not at all in various tumors and tumor cell lines (29). NDRG2 
is generally not expressed in monocytes or macrophages but 
is specifically expressed in dendritic cells (DCs) differentiated 
from monocytes, CD34
＋ progenitor cells, and the myelomo-
nocytic leukemic cell lines. In addition, it has been reported 
that NDRG2 expression in DCs modulates the T-cell stimulat-
i n g  c a p a b i l i t i e s  o f  D C s  v i a  c o - s t i m u l a t o r y  f a c t o r  e x p r e s s i o n  
(30). Therefore, NDRG2 may regulate immune responses via 
secretion  of  cytokine  such  as  IL-10  or  IL-12.
    Phorbol 13-myristate 12-acetate (PMA) is a known activator 
of  protein  kinase  C  (PKC)  and  the  Raf/MEK/Erk  pathway 
(31,32). It has been reported that preincubation of cells with 
PMA  inhibits  the  IL-6-induced  STAT3  and  STAT1  activation 
(33,34). This negative effect was found to be dependent on 
the activation of MAP kinases and transcription and protein 
synthesis.  Because  PMA  leads  to  a  rapid  upregulation  of 
SOCS3, a negative regulator of the JAK/STAT pathway, it is 
conceivable  that  the  inhibitory  effect  of  PMA  on  the 
JAK/STAT pathway is mediated by SOCS3 (35). In the present 
study, we chose PMA as a stimulator for IL-10 induction to 
investigate  SOCS3  and  STAT3  signaling.
    We  used  the  NDRG2-transfected  human  monocytic  cell 
line,  U937,  to  determine  whether  the  overexpression  of 
NDRG2 in U937 cells affected the ability of cells to produce 
IL-10.  Our  results  showed  that  whereas  IL-10  mRNA  after 
PMA  stimulation  increased  in  U937-mock  cells,  it  was  sig-
nificantly suppressed upon NDRG2 expression. As we were 
interested in SOCS3 signaling for IL-10 induction, mRNA lev-
els of SOCS genes (SOCS1-5) were investigated. Interestingly, 
SOCS3 expression increased upon PMA stimulation in U937- 
mock cells but was not significantly changed in U937-NDRG2 
cells, whereas the levels of other SOCS genes (SOCS1, 2, 4, 
5) showed no significant difference between U937-mock and 
U937-NDRG2 cells. Based on these data, it is reasonable to 
assume  that  IL-10  production  is  affected  by  SOCS3  expre-
ssion.
    STAT3, one of signaling molecules that controls IL-10 pro-
duction, is unphosphorylated and resides in the cytoplasm in 
normal resting cells. However, in response to various stimuli, 
STAT3  is activated through phosphorylation of tyrosine 705 
or serine 727, which promotes its homodimerization and sub-
sequent entry into the nucleus where the homodimers acti-
vate transcription (36). In particular, activation of STAT3 via 
phosphorylation of the tyrosine 705 residue induces the tran-
scription  of  genes  involved  in  inflammatory  responses  and 
cell proliferation and differentiation. STAT3 in immune cells 
can also induce genes involved in the inhibition of innate and 
adaptive immune responses that render resistance to tumors, 
and so it is expected that STAT3 negatively regulates immune NDRG2 Inhibits IL-10 Production in U937 Cells
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responses  against  tumors  (37).
    SOCS proteins are controlled in a STAT-dependent manner 
and  inhibit  the  JAK/STAT  pathway  by  a  negative  feedback 
loop. It has been reported that activation of ERK is essential 
for  SOCS3  induction  by  either  cyclic  AMP  or  PKC  (38).  In 
recent years, the SOCS proteins, which were first identified 
as rapidly inducible negative regulators of cytokine signaling, 
have emerged as key modulators of the cellular response to 
numerous biological stimuli. The SOCS proteins regulate the 
duration of the cytokine signaling response by both specific 
and non-specific regulatory mechanisms (39). Overexpression 
of SOCS3 in cell lines has shown that SOCS proteins can in-
hibit many cytokine-induced responses (23). For example, it 
has been reported that SOCS3 overexpression in human pe-
riodontal ligament (PDL) cells reduces the phosphorylation in 
downstream  signaling  molecules  including  STAT  (40). 
Furthermore,  enhanced  SOCS3  gene  expression  has  been 
found  to  promote  IL-10  production,  suggesting  that  STAT3 
and SOCS3 may play an important role in regulation of cyto-
kine-induced  anti-inflammatory  responses  (41).
    We examined protein levels of STAT3 and SOCS3 by west-
ern blot after PMA stimulation to determine the relationship 
between  IL-10  production  and  STAT3,  SOCS3,  and  NDRG2 
expression.  We  found  that  phosphorylated  STAT3  was  de-
creased in a time-dependent manner in U937-mock cells, but 
it was unchanged in U937-NDRG2 cells. By contrast, SOCS3 
was  suppressed  in  cells  overexpressing  NDRG2  but  main-
tained at high levels in U937-mock cells. Increased SOCS3 ex-
pression  after  PMA  stimulation  might  promote  IL-10 
p r o d u c t i o n .  T h e  f a c t  t h a t  S O C S 3  l e v e l s  w e r e  r e d u c e d  b y  
NDRG2  overexpression  but  STAT3  levels  were  maintained 
suggests that the negative feedback of SOCS3 was blocked. 
Blocking of STAT3 by specific inhibitors, such as cucurbitacin 
I, resulted in increased IL-10 production in both U937-mock 
and U937-NDRG2 cells, indicating a critical role for STAT3 in 
signaling  for  IL-10  production.
    To investigate the role of SOCS3 in IL-10 production in the 
context of NDRG2 expression, U937-mock and U937-NDRG2 
cells  were  transfected  with  specific  siRNAs  (siRNA  control, 
siSOCS3, siNDRG2). Upon stimulation with PMA, IL-10 mRNA 
was  decreased  in  U937-mock  cells  after  siRNA-mediated 
knockdown of SOCS3. Although there is a great deal of evi-
dence  showing  that  SOCS3  can  interfere  with  cytokine-in-
duced phosphorylation of STAT3 in immune cells (42,43), it 
i s  p r e s e n t l y  u n c l e a r  w h e t h e r  S T A T 3  r e c o v e r y  i s  d i r e c t l y  r e-
sponsible  for  the  reduction  of  IL-10  in  SOCS3-specific 
siRNA-transfected cells. Nonetheless, together with enhanced 
IL-10  gene  and  protein  expression  upon  treatment  with 
STAT3 inhibitors, our data clearly indicate that PMA-induced 
SOCS3 expression negatively regulates STAT3, leading to in-
creased production of IL-10. In this context, our data support 
the hypothesis that SOCS3 induced by IL-10 can participate 
in the inhibition of STAT3 that results in reduced expression 
of  proinflammatory  molecules.
    In this study, we report that SOCS3 expression was reduced 
by NDRG2-overexpression in U937-NDRG2 cells, and the de-
creased IL-10 production was restored by NDRG2 inhibition. 
These results indicate that NDRG2 inhibits IL-10 production 
through  the  inhibition  of  SOCS3  upon  PMA  stimulation. 
Taken  together,  our  data  suggest  that  NDRG2  expression 
modulates SOCS3 and STAT3 activity, leading to the inhibition 
of IL-10 production. Further study is required to identify the 
detailed mechanism of NDRG2 effects associated with MAPK 
or  other  possible  signaling  pathways  on  IL-10  production.
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